1 / 12

Radana Zachová Department of Immunology University hospital Motol, Charles University

Subcutaneous immunoglobulin replacement therapy for primary immunodeficiency in children and young adults. Radana Zachová Department of Immunology University hospital Motol, Charles University Prague, Czech Republic. ESID Prague Spring Meeting 2009.

satya
Download Presentation

Radana Zachová Department of Immunology University hospital Motol, Charles University

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Subcutaneous immunoglobulin replacement therapy for primary immunodeficiency in children and young adults. Radana Zachová Department of Immunology University hospital Motol, Charles University Prague, Czech Republic ESID Prague Spring Meeting 2009

  2. Immunoglobulin replacement therapy in primary immunodeficiencies Life –long therapy for patients with PID Possible administration ways – intravenous, subcutaneous Historically - intramuscular Disorders: CVID X- linked agammaglobulinemia Specific antibody deficiencies ESID Prague Spring Meeting 2009

  3. Subcutaneous immunoglobulin replacement therapy

  4. Small infusion pump for scig administration NOT refunded from insurance ! WE lend this pump from company

  5. Subcutaneous immunoglobulin replacement therapy in 1,5 year old boy. Case report: MK *2007 History: boy, 1. pregnancy, unrelative parents, born in term, 3100g, anorectal atresia, surgical treatment after delivery , 3 month - pyelonephritis 11 month - bilateral bronchopneumonia Immunoglobulin levels IgG, IgA, IgM – very low CD 19-1,1% CD 20-0,5% BTK mutation –pR28C missence mutation Family history: grandmother´s brother ( mother´s side) died at 18 years ( cerebral absces, recurrent bronchopneumonias)

  6. Subcutaneous immunoglobulin replacement therapy in 1,5 year old boy. MK *2007 Therapy: Immunolgobulin substitution therapy was indicated Weight : 10 kg after first application of IVIG mother refused intravenous application of immunoglobulins Intramuscular administration was started 1x in 14 days - painfull, uncomfortable - mother refused I.M. application too ↓ We started subcutaneous application of immunoglobulins

  7. Subcutaneous immunoglobulin replacement therapy in 1,5 year old boy. Thinks taken into consideration parents reffused IV and IM immunoglobulin substitution completelly subcutaneous therapy ? Disadvantages for SCIG low BMI – small subcutaneous tissue - big local swelling??? scar on abdominal wall after surgical treatment - only one side of abdominal wall can be used for replacement therapy 2 adult persons have to apply the therapy ( 1 has to fix the child) Actually: subcutaneous replacement therapy in home administration

  8. Subcutaneous immunoglobulin replacement therapy in 1,5 year old boy. MK *2007

  9. Subcutaneous immunoglobulin replacement therapy in 1,5 year old boy. MK *2007

  10. Our experience with SCIG therapy SCIG replacement therapy is not limited by age Patients pretreatet with IVIG may refuse SCIG SCIG is suitable for patients with previous adverse reactions to IVIG

  11. Thank you for your attention! ESID Prague Spring Meeting 2009

More Related